Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO PRESS RELEASE Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Further expansion of Ergomed’s presence in the strategically important US market MedSource’s...

Ergomed to Present at Jefferies Virtual 2020 Healthcare Conference  PRESS RELEASE Ergomed to Present at Jefferies Virtual 2020 Healthcare Conference Guildford, UK – 28 May 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing...

Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme PRESS RELEASE Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme Guildford, UK – 6 April 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the...

Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program PRESS RELEASE Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program Guildford, UK – 30 March 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the...